MedTrace Logo

Pyruvate Kinase Deficiency Natural History Study

NCT02053480 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 254

Last updated 2020-05-22

No results posted yet for this study

Summary

The purpose of this study is to describe the range and incidence of symptoms, treatments, and complications related to pyruvate kinase deficiency (PKD). Eligible patients are those of all ages with known PKD or with a hemolytic anemia and a family member with PKD. The study will collect retrospective medical history, routine clinical care data, and quality of life measures at baseline and annually for patients with PKD.

Conditions

  • Pyruvate Kinase Deficiency
  • Congenital Non-Spherocytic Hemolytic Anemia

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2019-12-31
Completion
2020-05-31

Countries

  • United States
  • Canada
  • Czechia
  • Germany
  • Italy
  • Netherlands

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02053480 on ClinicalTrials.gov